Chalkis Health Industry Co., Ltd / Fundamentals
Income statement
- Net revenue
€37.27M - Cost of goods sold
€41.66M - Gross profit
-€4.39M - SG&A expenses
€4.67M - R&D expenses
€424.22K - EBITDA
-€34.48M - D&A
-€1.03M - EBIT
-€36.88M - Interest expenses
€4.30M - EBT
-€38.78M - Tax expenses
€233.57K - Net income
-€38.40M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€12.30M - Changes in working capital
€0.00 - Operating cash flow
-€18.99M - Capex
€3.61M - Other investing cash flow
€51.08K - Net investing cash flow
-€3.56M - Total cash dividends paid
-€3.71M - Issuance of common stock
€0.00 - Debt repayment
€34.51M - Other financing cash flow
-€2.53M - Net financing cash flow
€28.27M - Foreign exchange effects
€0.21 - Net change in cash
-€4.63M - Cash at end of period
€6.18M - Free cash flow
-€15.38M
Balance sheet
- Cash and cash equivalents
€8.04M - Cash and short-term investments
€8.04M - Total receivables
€6.86M - Inventory
€87.69M - Other current assets
€8.19M - Total current assets
€110.77M - Property, plant & equipment
€52.31M - Goodwill
€0.00 - Intangible assets
€2.04M - Long-term investments
€0.00 - Other non-current assets
€1.90M - Total non-current assets
€56.35M - Total assets
€167.12M - Accounts payable
€8.24M - Short-term debt
€73.68M - Other current liabilities
€74.45M - Total current liabilities
€156.48M - Long-term debt
€8.04M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€2.59M - Total non-current liabilities
€22.00M - Total liabilities
€178.48M - Common stock
€93.35M - Retained earnings
-€239.79M - Other equity
€0.00 - Total equity
-€11.36M - Total liabilities and shareholders' equity
€167.12M
Company information
- Market capitalization
€326.70M - Employees
620 - Enterprise Value
€3.38B
Company ratios
- Gross margin
-
-11.8% Much worse than peer group: 16.8% - EBITDA margin
-
-92.5% Much worse than peer group: 9.6% - EBIT margin
-
-99.0% Much worse than peer group: -0.3% - EBT margin
-
-104.1% Much worse than peer group: 0.3% - Net margin
-
-103.0% Much worse than peer group: -0.1% - ROE
-
338.1% Much better than peer group: 2.3% - ROA
-
-23.0% Much worse than peer group: 1.3% - Asset turnover
-
22.3% Much worse than peer group: 54.0% - FCF margin
-
-60.7% Much worse than peer group: -3.3% - FCF yield
-6.9% - Efficiency ratio
192.5% - Net sales per employee
-
€60.11K - Net income per employee
-
-€61.93K